TMEM132A

gene
On this page

Also known as GBPFLJ20539

Summary

TMEM132A (transmembrane protein 132A, HGNC:31092) is a protein-coding gene on chromosome 11q12.2, encoding Transmembrane protein 132A (Q24JP5). May play a role in embryonic and postnatal development of the brain.

This gene encodes a protein that is highly similar to the rat Grp78-binding protein (GBP). Alternatively spliced transcript variants encoding different isoforms have been described.

Source: NCBI Gene 54972 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 190 total
  • MANE Select transcript: NM_178031

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31092
Approved symbolTMEM132A
Nametransmembrane protein 132A
Location11q12.2
Locus typegene with protein product
StatusApproved
AliasesGBP, FLJ20539
Ensembl geneENSG00000006118
Ensembl biotypeprotein_coding
OMIM617363
Entrez54972

Gene structure

Transcript identifiers

Ensembl transcripts: 14 — 6 protein_coding, 5 protein_coding_CDS_not_defined, 3 retained_intron

ENST00000005286, ENST00000453848, ENST00000534983, ENST00000535480, ENST00000536409, ENST00000536928, ENST00000537065, ENST00000537110, ENST00000538090, ENST00000540112, ENST00000540276, ENST00000543732, ENST00000544065, ENST00000544098

RefSeq mRNA: 2 — MANE Select: NM_178031 NM_017870, NM_178031

CCDS: CCDS44618, CCDS7997

Canonical transcript exons

ENST00000453848 — 11 exons

ExonStartEnd
ENSE000007212976093525260935443
ENSE000008514456093354260933744
ENSE000013603496093586460937159
ENSE000022376266092446060924733
ENSE000035272786093168960931884
ENSE000035371526092862960928960
ENSE000035424506093198460932127
ENSE000036011386092764160927859
ENSE000036272516093448860934764
ENSE000036337786092720460927418
ENSE000037881206093051060930659

Expression profiles

Bgee: expression breadth ubiquitous, 214 present calls, max score 98.35.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 28.9487 / max 413.4082, expressed in 1507 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
11452828.54971505
1145290.3523217
1145260.046622

Top tissues by expression

272 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534398.35gold quality
ganglionic eminenceUBERON:000402397.36gold quality
right hemisphere of cerebellumUBERON:001489097.19gold quality
right frontal lobeUBERON:000281096.99gold quality
cerebellar hemisphereUBERON:000224596.74gold quality
cerebellar cortexUBERON:000212996.66gold quality
amygdalaUBERON:000187696.32gold quality
prefrontal cortexUBERON:000045196.28gold quality
anterior cingulate cortexUBERON:000983596.24gold quality
cingulate cortexUBERON:000302796.23gold quality
cerebellumUBERON:000203795.68gold quality
Brodmann (1909) area 9UBERON:001354095.34gold quality
putamenUBERON:000187494.84gold quality
dorsolateral prefrontal cortexUBERON:000983494.84gold quality
caudate nucleusUBERON:000187394.78gold quality
neocortexUBERON:000195094.59gold quality
ventricular zoneUBERON:000305394.53gold quality
frontal cortexUBERON:000187094.46gold quality
nucleus accumbensUBERON:000188294.25gold quality
stromal cell of endometriumCL:000225594.05gold quality
hypothalamusUBERON:000189893.78gold quality
lower esophagus mucosaUBERON:003583493.33gold quality
telencephalonUBERON:000189393.26gold quality
cerebral cortexUBERON:000095693.23gold quality
brainUBERON:000095592.82gold quality
forebrainUBERON:000189092.75gold quality
temporal lobeUBERON:000187192.66gold quality
lateral globus pallidusUBERON:000247691.88gold quality
embryoUBERON:000092291.83gold quality
dorsal motor nucleus of vagus nerveUBERON:000287090.64gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-84465yes274.01
E-CURD-10yes44.36
E-ANND-3no2.84

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): E2F1

miRNA regulators (miRDB)

12 targeting TMEM132A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-29A-3P100.0073.111835
HSA-MIR-29B-3P100.0073.181833
HSA-MIR-29C-3P100.0073.151833
HSA-MIR-498-3P99.9171.271114
HSA-MIR-468899.4864.68828
HSA-MIR-4652-3P99.3370.022742
HSA-MIR-6868-3P98.6369.642259
HSA-MIR-4778-5P97.9668.061634
HSA-MIR-393697.6464.47732
HSA-MIR-6787-5P97.5463.85457
HSA-MIR-4652-5P96.4664.22553
HSA-MIR-1908-5P94.9963.41352

Literature-anchored findings (GeneRIF, showing 1)

  • describes characterization of the rat protein (PMID:12514190)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriosi:dkey-1d7.3ENSDARG00000075837
mus_musculusTmem132aENSMUSG00000024736
rattus_norvegicusTmem132aENSRNOG00000021338
drosophila_melanogasterdtnFBGN0262730
caenorhabditis_elegansWBGENE00022175

Paralogs (4): TMEM132B (ENSG00000139364), TMEM132D (ENSG00000151952), TMEM132C (ENSG00000181234), TMEM132E (ENSG00000181291)

Protein

Protein identifiers

Transmembrane protein 132AQ24JP5 (reviewed: Q24JP5)

Alternative names: HSPA5-binding protein 1

All UniProt accessions (5): Q24JP5, F5H765, H0YFB3, H0YFQ1, H0YFQ2

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in embryonic and postnatal development of the brain. Increased resistance to cell death induced by serum starvation in cultured cells. Regulates cAMP-induced GFAP gene expression via STAT3 phosphorylation.

Subunit / interactions. Interacts with HSPA5/GRP78.

Subcellular location. Golgi apparatus membrane. Endoplasmic reticulum membrane.

Similarity. Belongs to the TMEM132 family.

Isoforms (4)

UniProt IDNamesCanonical?
Q24JP5-11yes
Q24JP5-22
Q24JP5-33
Q24JP5-44

RefSeq proteins (2): NP_060340, NP_821174* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026307TMEM132Family
IPR031435TMEM132_NDomain
IPR031436TMEM132_CDomain
IPR031437Ig_TMEM132_4thDomain
IPR055421TMEM132_3rdDomain
IPR055422Ig_TMEM132_2ndDomain
IPR055423Ig_TMEM132_5thDomain
IPR055424Ig_TMEM132_6thDomain

Pfam: PF15705, PF15706, PF16070, PF23039, PF23481, PF23486, PF23487

UniProt features (26 total): region of interest 6, splice variant 5, compositionally biased region 4, topological domain 2, sequence variant 2, sequence conflict 2, signal peptide 1, chain 1, modified residue 1, glycosylation site 1, transmembrane region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q24JP5-F173.410.35

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 529

Glycosylation sites (1): 280

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-381426Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
R-HSA-8957275Post-translational protein phosphorylation
R-HSA-392499Metabolism of proteins
R-HSA-597592Post-translational protein modification

MSigDB gene sets: 135 (showing top): TGGTGCT_MIR29A_MIR29B_MIR29C, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, GOBP_CELL_CELL_SIGNALING, GOBP_REGULATION_OF_PROTEIN_SECRETION, GOBP_REGULATION_OF_CATABOLIC_PROCESS, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, GOBP_SECRETION, GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, GOBP_SIGNAL_RELEASE, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON

GO Biological Process (3): positive regulation of Wnt signaling pathway (GO:0030177), negative regulation of protein catabolic process (GO:0042177), positive regulation of Wnt protein secretion (GO:0061357)

GO Molecular Function (1): protein homodimerization activity (GO:0042803)

GO Cellular Component (8): Golgi membrane (GO:0000139), endoplasmic reticulum (GO:0005783), endoplasmic reticulum lumen (GO:0005788), endoplasmic reticulum membrane (GO:0005789), plasma membrane (GO:0005886), extracellular exosome (GO:0070062), Golgi apparatus (GO:0005794), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Metabolism of proteins2
Post-translational protein modification1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm2
endomembrane system2
intracellular membrane-bounded organelle2
positive regulation of signal transduction1
Wnt signaling pathway1
regulation of Wnt signaling pathway1
negative regulation of catabolic process1
protein catabolic process1
regulation of protein catabolic process1
negative regulation of protein metabolic process1
positive regulation of cell communication1
positive regulation of signaling1
positive regulation of protein secretion1
Wnt protein secretion1
regulation of Wnt protein secretion1
identical protein binding1
protein dimerization activity1
Golgi apparatus1
bounding membrane of organelle1
endoplasmic reticulum1
intracellular organelle lumen1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
membrane1
cell periphery1
extracellular vesicle1
cellular anatomical structure1

Protein interactions and networks

STRING

586 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM132AHSPA5P11021625
TMEM132ATMEM62Q0P6H9512
TMEM132ATMED6Q8WW62478
TMEM132AFHIP2BQ86V87437
TMEM132ATMEM164Q5U3C3416
TMEM132AMS4A10Q96PG2406
TMEM132AMGAT5BQ3V5L5385
TMEM132ANAV2Q8IVL1385
TMEM132ATMEM59Q9BXS4370
TMEM132ACDCP2Q5VXM1359
TMEM132ACDHR2Q9BYE9356
TMEM132ATMEM109Q9BVC6351
TMEM132ANKAPD1Q6ZUT1321
TMEM132AST8SIA5O15466311
TMEM132ASINHCAFQ9NP50311

IntAct

98 interactions, top by confidence:

ABTypeScore
B3GNT3PGRMC1psi-mi:“MI:0914”(association)0.670
CRIPTOAIPpsi-mi:“MI:0914”(association)0.640
MGAT4CGXYLT2psi-mi:“MI:0914”(association)0.530
DEFA5NUDT19psi-mi:“MI:0914”(association)0.530
DEFA1MANBApsi-mi:“MI:0914”(association)0.530
CALR3UBR5psi-mi:“MI:0914”(association)0.530
DNASE2BARSApsi-mi:“MI:0914”(association)0.530
C1orf54EXTL3psi-mi:“MI:0914”(association)0.530
SPCS3ENTPD6psi-mi:“MI:0914”(association)0.530
ANTXR1WFS1psi-mi:“MI:0914”(association)0.530
MEGF10TMEM132Apsi-mi:“MI:0915”(physical association)0.370
TMEM132AWWP2psi-mi:“MI:0914”(association)0.350
CCN1psi-mi:“MI:0914”(association)0.350
DYRK1ATEX13Dpsi-mi:“MI:0914”(association)0.350
ITM2BILVBLpsi-mi:“MI:0914”(association)0.350
CACNA1CSYT5psi-mi:“MI:0914”(association)0.350
CACNA1CIGLL5psi-mi:“MI:0914”(association)0.350
CACNA1CCACNB4psi-mi:“MI:0914”(association)0.350
HCN1POTEFpsi-mi:“MI:0914”(association)0.350
CACNA1CDISP2psi-mi:“MI:0914”(association)0.350
SYNGAP1IGLON5psi-mi:“MI:0914”(association)0.350
MFAP4CRLF1psi-mi:“MI:0914”(association)0.350
TMEM106AQSOX1psi-mi:“MI:0914”(association)0.350
PCDHGA9TMEM223psi-mi:“MI:0914”(association)0.350
HLA-DRATMEM223psi-mi:“MI:0914”(association)0.350
CLEC12BGXYLT2psi-mi:“MI:0914”(association)0.350
ST8SIA4FAM234Bpsi-mi:“MI:0914”(association)0.350
NAAAPOTEFpsi-mi:“MI:0914”(association)0.350
LLCFC1POTEFpsi-mi:“MI:0914”(association)0.350

BioGRID (149): TMEM132A (Affinity Capture-RNA), TMEM132A (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), COX6B1 (Affinity Capture-MS), DBI (Affinity Capture-MS), FYN (Affinity Capture-MS), GOLGA2 (Affinity Capture-MS), NDST1 (Affinity Capture-MS)

ESM2 similar proteins: A1A4M2, A4IFG4, A5D8P8, A6NKD9, A7E2M3, B4F7F3, E9Q6B2, F1MX48, F1SAM7, O97676, P18065, P36956, P47877, P49705, P56720, P56873, Q00709, Q00973, Q09200, Q0IHY5, Q15465, Q24JP5, Q2YD98, Q3TAS6, Q58CS8, Q5QQ49, Q5UCC4, Q60416, Q60698, Q641Q3, Q68FE7, Q6AYH6, Q6DVA0, Q6P7K5, Q6UKI2, Q6WVG3, Q80WF4, Q8IW70, Q8JGM4, Q8K064

Diamond homologs: L7VG99, Q14C87, Q14DG7, Q24JP5, Q6IEE6, Q6IEE7, Q76HP2, Q76HP3, Q80WF4, Q8CEF9, Q8N3T6, Q922P8

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 133 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Neutrophil degranulation174.4×6e-05
Innate Immune System154.3×3e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

190 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance170
Likely benign6
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1969 predictions. Top by Δscore:

VariantEffectΔscore
11:60926689:G:Tdonor_gain1.0000
11:60926696:G:GTdonor_gain1.0000
11:60927202:A:AGacceptor_gain1.0000
11:60927203:G:GGacceptor_gain1.0000
11:60927639:AGGT:Aacceptor_gain1.0000
11:60927640:GGTG:Gacceptor_gain1.0000
11:60928958:GCG:Gdonor_gain1.0000
11:60928961:G:GAdonor_loss1.0000
11:60928961:G:GGdonor_gain1.0000
11:60928962:T:Gdonor_loss1.0000
11:60930505:CCCA:Cacceptor_loss1.0000
11:60930506:CCA:Cacceptor_loss1.0000
11:60930508:A:AGacceptor_gain1.0000
11:60930508:AG:Aacceptor_gain1.0000
11:60930509:G:Aacceptor_gain1.0000
11:60930509:G:GTacceptor_gain1.0000
11:60930509:GGAT:Gacceptor_gain1.0000
11:60930509:GGATC:Gacceptor_gain1.0000
11:60930656:CCAG:Cdonor_loss1.0000
11:60930658:AGGTG:Adonor_loss1.0000
11:60930659:GGT:Gdonor_loss1.0000
11:60930660:G:Cdonor_loss1.0000
11:60930661:T:Gdonor_loss1.0000
11:60931685:GCA:Gacceptor_gain1.0000
11:60932125:CAG:Cdonor_loss1.0000
11:60932126:AG:Adonor_loss1.0000
11:60932127:GG:Gdonor_loss1.0000
11:60932128:GT:Gdonor_loss1.0000
11:60932129:T:Adonor_loss1.0000
11:60934761:TGAGG:Tdonor_loss1.0000

AlphaMissense

6470 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:60936832:G:CW999C0.999
11:60936832:G:TW999C0.999
11:60936728:T:CF965L0.998
11:60936730:T:AF965L0.998
11:60936730:T:GF965L0.998
11:60936830:T:AW999R0.998
11:60936830:T:CW999R0.998
11:60936520:G:CW895C0.997
11:60936520:G:TW895C0.997
11:60936729:T:GF965C0.997
11:60936891:T:CI1019T0.997
11:60931777:T:AW369R0.995
11:60931777:T:CW369R0.995
11:60936837:G:AC1001Y0.995
11:60927753:T:CF143S0.994
11:60936729:T:CF965S0.994
11:60933721:G:CW512C0.993
11:60933721:G:TW512C0.993
11:60934736:G:AG603D0.993
11:60931772:T:AV367D0.992
11:60933719:T:AW512R0.992
11:60933719:T:CW512R0.992
11:60932098:T:AC443S0.991
11:60932099:G:CC443S0.991
11:60934560:G:CQ544H0.991
11:60934560:G:TQ544H0.991
11:60934706:C:AA593D0.991
11:60935898:A:TD688V0.991
11:60936836:T:AC1001S0.991
11:60936836:T:CC1001R0.991

dbSNP variants (sampled 300 via entrez): RS1000126500 (11:60935104 G>A), RS1000342054 (11:60923591 G>A), RS1000465634 (11:60933971 C>T), RS1000589341 (11:60927990 C>A,T), RS1000647072 (11:60924436 C>T), RS1000676786 (11:60924551 C>A,T), RS1000816634 (11:60934242 C>A,T), RS1000938560 (11:60930324 G>A,C), RS1001537757 (11:60934421 A>C), RS1001810936 (11:60922624 T>C), RS1001985966 (11:60933602 G>A,T), RS1002178861 (11:60924199 C>T), RS1002589490 (11:60933360 T>G), RS1002656945 (11:60927109 C>A,G), RS1002808677 (11:60936979 C>A,T)

Disease associations

OMIM: gene MIM:617363 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST006585_31Blood protein levels5.000000e-113

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

30 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Tobacco Smoke Pollutionaffects expression, decreases expression, increases expression3
Estradiolaffects cotreatment, decreases expression, increases expression2
aristolochic acid Iincreases expression1
FR900359increases phosphorylation1
methyleugenolincreases expression1
propylparabenincreases expression1
beta-lapachonedecreases expression1
methylparabenincreases expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
cupric chlorideincreases expression1
perfluorodecanoic aciddecreases expression1
S-(1,2-dichlorovinyl)cysteinedecreases expression1
perfluoro-n-nonanoic aciddecreases expression1
abrineincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Temozolomideincreases expression1
Zoledronic Acidincreases expression1
Acetaminophenincreases expression1
Cadmiumincreases expression1
Caffeinedecreases phosphorylation1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Dexamethasonedecreases expression1
Doxorubicindecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Progesteroneaffects cotreatment, decreases expression1
Smokedecreases expression1
Cadmium Chlorideincreases expression1
Okadaic Acidincreases expression1
tert-Butylhydroperoxideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.